News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Contraception news

Show

From To
Contraception
The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest

Because Depo-Provera is an important contraceptive choice and because in many parts of the world, it is the only long-acting, discreet option available to women, it is vital to take the issue of a link between HIV and hormonal contraception quite seriously while adding nuance to the discussion.

Published
27 January 2016
From
RH Reality Check
PrEP
Lessons learnt from the history of contraception are relevant for the implementation of PrEP

Achieving a widespread and appropriate use of pre-exposure prophylaxis (PrEP) will take several years and will require considerable attention to the shape and quality of health services,

Published
06 January 2016
By
Roger Pebody
Contraception
Hormonal contraception safe for women with HIV and may have important health benefits

HIV-positive women can safely use hormonal contraception, according to research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Hormonal implants and injectable

Published
06 November 2015
By
Michael Carter
Contraception
Vaginal Infections May Help Explain Link Between Hormonal Contraception and Increased HIV Risk

Hormones may alter genital tract immunity in a way that makes women more prone to bacterial and viral infections, while disturbances in natural vaginal microbes may also contribute to the association seen in some studies between use of hormonal contraceptives such as Depo-Provera and susceptibility to HIV infection, according to a laboratory study published in the online journal mBio.

Published
03 October 2015
From
HIVandHepatitis.com
Contraception
Implant and injectable hormonal contraception most effective methods for women living with HIV

Hormonal contraceptive methods are highly effective in reducing the risk of pregnancy in women living with HIV whether on antiretroviral therapy (ART) or not, according to an evaluation

Published
29 July 2015
By
Carole Leach-Lemens
Experiences of stigma
HIV-positive women bear brunt of stigma

South Africa’s first national HIV stigma survey has found that 7 percent of HIV-positive women surveyed reported being sterilised against their will. About 40 percent said contraception use had been a pre-requisite to accessing antiretroviral (ARV) treatment, contrary to national policy.

Published
12 June 2015
From
Independent Online
Contraception
FDA Asked To Add HIV Warning To Birth Control Label

Nearly two dozen doctors and scientists have signed off on a citizen petition to the U.S. Food and Drug Administration urging the agency to add language to Pfizer Inc.’s Depo-Provera birth control shot indicating that the shot could increase a woman’s chances of being infected with HIV.

Published
03 June 2015
From
Law 360
Contraception
Tense debate over ethics of trial on link between HIV, contraception

Thus far, most evidence pertaining to the use of Depo-Provera and the risk of HIV-infection come from observational studies, which can reveal whether two factors are associated with each other, but cannot determine whether one is causing the other to occur. Given this limitation, some scholars are looking to develop a randomised controlled trial, an experimental study that is better at determining cause and effect.

Published
01 May 2015
From
Mail & Guardian
Human rights
S.Africa HIV-positive women forced to sterilise: rights groups

Doctors at some public hospitals in South Africa have allegedly coerced dozens of HIV-positive women to undergo sterilisation over the past three decades, rights groups said Thursday.

Published
20 March 2015
From
Yahoo News
Contraception
The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest

A newly published study is stirring up questions about the relationship between Depo-Provera, and other progestogen-only injectable contraceptives, and the risk of HIV acquisition among HIV-negative women. The study triggered a wave of headlines and tweets that boiled down the complexities and caveats of this analysis into an oversimplified statement: Depo increases women’s risk of HIV by 40 percent.

Published
14 January 2015
From
RH Reality Check
← Prev1...23456...13Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.